Literature DB >> 12412693

Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients.

M Cruciani1, P Marcati, M Malena, O Bosco, G Serpelloni, C Mengoli.   

Abstract

Sputum induction is a simple and noninvasive procedure for Pneumocystis carinii pneumonia (PCP) diagnosis in human immunodeficiency virus-1-positive patients, although less sensitive than bronchoalveolar lavage (BAL). In order to obtain an overview of the diagnostic accuracy of sputum induction, a systematic review and meta-analysis of studies reporting the comparative sensitivity and specificity of BAL (the "gold standard") and sputum induction was performed. The odds ratio and related 95% confidence interval were calculated using summary receiving operating characteristic curves as well as fixed-effect and random-effect models. Based on pooled data, the negative and positive predictive values were calculated for a range of PCP prevalence using a Bayesian approach. Seven prospective studies assessed the comparative accuracy of BAL and sputum induction. On the whole, sputum induction demonstrated 55.5% sensitivity and 98.6% specificity. The sensitivity of sputum induction was significantly higher with immunofluorescence than with cytochemical staining (67.1 versus 43.1%). In settings of 25-60% prevalence of PCP, the positive and negative predictive values ranged 86-96.7 and 66.2-89.8, respectively, with immunofluorescence, and 79-94.4 and 53-83.5% with cytochemical staining. In conclusion, in a setting of low prevalence of Pneumocystis carinii pneumonia, sputum induction, particularly with immunostaining, appears to be adequate for clinical decision-making.

Entities:  

Mesh:

Year:  2002        PMID: 12412693     DOI: 10.1183/09031936.02.01372002

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

Review 1.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 2.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

Review 3.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

4.  Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.

Authors:  D Salerno; D Mushatt; L Myers; Y Zhuang; N de la Rua; E J Calderon; D A Welsh
Journal:  Respir Med       Date:  2014-11       Impact factor: 3.415

5.  Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.

Authors:  Paul E Sax; Lauren Komarow; Malcolm A Finkelman; Philip M Grant; Janet Andersen; Eileen Scully; William G Powderly; Andrew R Zolopa
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

6.  Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.

Authors:  Wei-Jie Li; Ya-Ling Guo; Tang-Juan Liu; Ke Wang; Jin-Liang Kong
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

7.  Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.

Authors:  Brian R Wood; Lauren Komarow; Andrew R Zolopa; Malcolm A Finkelman; William G Powderly; Paul E Sax
Journal:  AIDS       Date:  2013-03-27       Impact factor: 4.177

Review 8.  Pulmonary Infections in Immunocompromised Hosts: Clinical.

Authors:  Cristina Vazquez Guillamet; Joe Le Hsu; Gundeep Dhillon; Rodrigo Vazquez Guillamet
Journal:  J Thorac Imaging       Date:  2018-09       Impact factor: 3.000

9.  Pneumocystis pneumonia in HIV-positive adults, Malawi.

Authors:  Joep J G van Oosterhout; Miriam K Laufer; M Arantza Perez; Stephen M Graham; Nelson Chimbiya; Phillip C Thesing; Miriam J Alvarez-Martinez; Paul E Wilson; Maganizo Chagomerana; Eduard E Zijlstra; Terrie E Taylor; Christopher V Plowe; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

10.  Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer.

Authors:  Tsuyoshi Shinohara; Makito Yasui; Hiroyuki Yamada; Yoshiro Fujimori; Kiyofumi Yamagishi
Journal:  Case Rep Oncol Med       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.